[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353922-105":59,"doc-detail-353922-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-likely-possibility-of-predicting-treatment-outcomes-of-cervical-lesions-using-serum-foxp3-and-p16ink4a-cohort-study-in-southwestern-uganda","The likely possibility of predicting treatment outcomes of cervical lesions using serum FOXP3 and P16INK4A - cohort study in SouthWestern Uganda","","There is a need for blood-based biomarkers to assess treatment outcomes of cervical lesions. A prospective cohort study at a clinic in Southwestern Uganda evaluated the association between serum P16ink4A and FOXP3 concentrations and outcomes. Participants with cervical intraepithelial neoplasia and cervical cancer were followed for 12 months with baseline and post-treatment quantitative ELISA measurements. Multinomial logistic regression assessed links between biomarker levels and cleared, persistent, or progressed disease. Results suggested likely associations with persistence and progression.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-likely-possibility-of-predicting-treatment-outcomes-of-cervical-lesions-using-serum-foxp3-and-p16ink4a-cohort-study-in-southwestern-uganda/353922/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-likely-possibility-of-predicting-treatment-outcomes-of-cervical-lesions-using-serum-foxp3-and-p16ink4a-cohort-study-in-southwestern-uganda/353922.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main purpose of the study?","Question",{"text":113,"@type":114},"To evaluate whether serum FOXP3 and P16INK4A can predict treatment outcomes of cervical lesions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were participants and biomarkers assessed?",{"text":118,"@type":114},"Participants with confirmed cervical intraepithelial neoplasia and cervical cancer were monitored for 12 months, and serum P16INK4A and FOXP3 were measured at baseline and 12 months using quantitative ELISA.",{"name":120,"@type":111,"acceptedAnswer":121},"What outcomes did the study track?",{"text":122,"@type":114},"Cleared lesions, persistent lesions, and progressed lesions were assessed at the 12-month follow-up.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353922,1790146253,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Ssedyabane etal. Discover Oncology (2026) 17:464  \n[https://doi.org/10.1007/s12672-026-04670-5](https://doi.org/10.1007/s12672-026-04670-5)  \nDiscover Oncology  \nRESEARCH Open Access  \nThe likely possibility of predicting treatment outcomes of cervical lesions using serum FOXP3 and P16INK4A as shown by a cohort study in SouthWestern Uganda  \nFrank Ssedyabane1*, Deusdedit Tusubira5, Nixon Niyonzima3, Josephine Nambi Najjuma6, Thomas C. Randall4, Rogers Kajabwangu2, Cesar M. Castro7,8, Hakho Lee7,9 and Joseph Ngonzi2  \n*Correspondence:  \nFrank Ssedyabane [fssedyabane@must.ac.ug](fssedyabane@must.ac.ug)[ ](fssedyabane@must.ac.ug)1Department of Medical Laboratory Science, Faculty of Medicine, Mbarara University of Science and Technology, P. O. Box 1410, Mbarara, Uganda  \n2Department of Obstetrics and Gynecology, Mbarara University of Science of Science and Technology, P. O. Box 1410, Mbarara, Uganda 3Research and Training Directorate, Uganda Cancer Institute, P. O. Box 3935, Kampala, Uganda 4Department of Obstetrics and Gynecology, Columbia University, New York, USA  \n5Department of Biochemistry, Mbarara University of Science of Science and Technology, P. O. Box 1410, Mbarara, Uganda 6Department of Nursing, Mbarara University of Science of Science and Technology, P. O. Box 1410, Mbarara, Uganda  \n7Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA  \n8Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA 9Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA  \nAbstract  \nIntroduction There is a need to assess the potential of blood-based biomarkers to detect treatment outcomes of cervical lesions. We determined the association between serum P16ink4A and FOXP3 concentrations and treatment outcomes of cervical lesions at a clinic in Southwestern Uganda.  \nMethods In this prospective cohort study, participants with cytologically and/or histologically confirmed cervical intraepithelial neoplasia (CIN) (n = 90) and cervical cancer (CC) (n = 90) were monitored for 12 months. After consent, clinical and demographic data were recorded, blood was collected, and serum P16ink4A and FOXP3 were measured (quantitative ELISA) at baseline and 12 months post-treatment. With multinomial logistic regression, we determined the association between treatment outcomes and serum P16ink4A and FOXP3 concentrations in STATA 17 using P-values of \u003C 0.05 as statistically significant.  \nResults Of the 180 participants initially enrolled, 62 returned for the 12-month follow-up assessment. At this time point, 47 participants presented with cleared lesions, 6 with persistent lesions, and 9 with progressed lesions. All participants exhibiting disease progression (n = 9) were CC cases, while 82 . 98%(39/47) of those with cleared lesions had LSIL. For raised (> 0.0545 ng/ml), relative to reduced serum FOXP3 (≤ 0.0545 ng/ml), the risk of progression relative to clearance of invasive cervical cancer would increase by 27.82. Also raised (> 0.946 ng/ml) relative to reduced (≤ 0.946 ng/ml) serum P16INK4A, the risk of persistence relative to clearance of low grade cervical lesions would increase by 5.16 times, given other variables remain constant.  \nConclusion Though results are not statistically significant and imprecise, serum FOXP3 and P16ink4A concentrations are likely associated with persistence and progression of cervical lesions. Their measurement may benefit the prognostic monitoring of cervical lesions.  \nKeywords Cervical intraepithelial neoplasia, Cervical cancer, P16ink4A, FOXP3, Persistence, Progression, Clearance  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original a","cbCaivipbz8MV7NC","https://ap.wps.com/l/cbCaivipbz8MV7NC","pdf",1218728,17,"English","# Introduction\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What was the main purpose of the study?\",\"answer\":\"To evaluate whether serum FOXP3 and P16INK4A can predict treatment outcomes of cervical lesions.\"},{\"question\":\"How were participants and biomarkers assessed?\",\"answer\":\"Participants with confirmed cervical intraepithelial neoplasia and cervical cancer were monitored for 12 months, and serum P16INK4A and FOXP3 were measured at baseline and 12 months using quantitative ELISA.\"},{\"question\":\"What outcomes did the study track?\",\"answer\":\"Cleared lesions, persistent lesions, and progressed lesions were assessed at the 12-month follow-up.\"}]","The likely possibility of predicting treatment outcomes of cervical lesions using serum FOXP3 and P16INK4A - cohort study in SouthWestern Uganda | PDF",1790107930,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8848e28ecf198391487f9b966710b39.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4835ff0e846d1c9b8bea86dc0053502d.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a9051248617b31eb8841293fc8b4307.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e691f956aae71c4db3216c5e7bbdc385.webp",980,1306]